49 results on '"Guerrini, R."'
Search Results
2. Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies—An Italian observational multicenter study
3. An integrated fMRI, SEPs and MEPs approach for assessing functional organization in the malformed sensorimotor cortex
4. Multicenter prospective longitudinal study in 34 patients with Dravet syndrome: Neuropsychological development in the first six years of life
5. GALNS gene expression profiling in Morquio A patients' fibroblasts
6. Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity
7. Does 7T MRI reveal a neuronal bridge between periventricular heterotopia and overlying cortical malformations?
8. Hypocitrullinemia in expanded newborn screening by LC–MS/MS is not a reliable marker for ornithine transcarbamylase deficiency
9. Retrospective evaluation of low long-term efficacy of antiepileptic drugs and ketogenic diet in 39 patients with CDKL5-related epilepsy.
10. Extremely sustained startle-induced clonus: Non epileptic motor attacks mimicking clonic seizures in children with encephalopathy.
11. Early add-on immunoglobulin administration in Rasmussen encephalitis: The hypothesis of neuroimmunomodulation.
12. The gastric effects of UFP-112, a new nociceptin/orphanin receptor agonist, in physiological and pathological conditions
13. Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat
14. P.2.017 Antinociceptive effects of intrathecally administered nociceptin/orphanin FQ receptor agonists in the rat tail flick test
15. Development and characterisation of a novel fluorescent NOP ligand-N/OFQATTO.
16. 426 Intravesical nociceptin/orphanin FQ (N/OFQ) in patients with neurogenic detrusor overactivity: Two years of experience
17. Continuous intravesical infusion of nociceptin/orphanin (N/OFQ) by in situ drug delivery system to treat refractory neurogenic detrusor overactivity
18. Urodynamic effects of intravesical nociceptin/orphanin FQ in patients with overactive bladder — A randomised, placebo-controlled, double-blind study
19. P51 – 1765 Safety and potential impact on growth and developmental skills of long-term adjunctive zonisamide therapy in paediatric patients with partial epilepsy.
20. PP7.5 – 1768 Efficacy of long-term adjunctive zonisamide therapy in paediatric patients with partial epilepsy: results of an open-label extension study of a Phase III, randomised, double-blind, placebo-controlled trial.
21. P14.6 Phase III, double-blind, randomised, placebo-controlled trial of adjunctive zonisamide treatment in paediatric patients with partial-onset seizures (Catz study): Current status.
22. 2FC1.4 Epilepsy in girls with de novo protocadherin 19 mutations.
23. P199 Clinical and molecular evaluation of 14 Turkish patients with Dravet syndrome.
24. Design of μ selective opioid dipeptide antagonists
25. Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505).
26. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions
27. Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series.
28. Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.
29. Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands.
30. In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1.
31. Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation
32. [ t Bu-d-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies
33. Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor
34. Carbamoyl Phosphate Synthetase 1 deficiency in Italy: Clinical and genetic findings in a heterogeneous cohort
35. Functional studies of new GLA gene mutations leading to conformational fabry disease
36. Lithium attenuates behavioral and biochemical effects of neuropeptide S in mice
37. Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: A comparative study with amphetamine and diazepam
38. Reorganisation of the somatosensory system after early brain damage
39. Functional nociceptin receptors are upregulated on human umbilical vein endothelial cells during experimental in vitro sepsis.
40. Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation
41. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells
42. Pharmacological profile of hemokinin 1: a novel member of the tachykinin family
43. Hemiconvulsion–hemiplegia–epilepsy syndrome: Early magnetic resonance imaging findings and neuroradiological follow-up
44. Characterisation of dermorphinATTO488 at recombinant mu opioid peptide receptors.
45. Evidence for nociceptin opioid peptide receptor (NOP) expression and nociceptin/orphanin FQ (N/OFQ) release from live B and T cells.
46. Characterization of the bifunctional opioid UFP505.
47. P2.17 Non invasive functional mapping in children with symptomatic perirolandic seizures: the contribution of functional MRI during passive motor tasks
48. S2.5 An integrated multimodal approach for assessing functional reorganization in unilateral polymicrogyria
49. P23-14 Action myoclonus in sialidosis: a comparative study with Unverricht-Lundborg disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.